Movement disorders News and Research

RSS
Novel mechanism linking intercellular adhesion molecule with genetic skin diseases discovered

Novel mechanism linking intercellular adhesion molecule with genetic skin diseases discovered

Study provides better understanding of the degenerative underpinnings of Parkinson’s disease

Study provides better understanding of the degenerative underpinnings of Parkinson’s disease

Length of the lipid chains predicts a person's risk for Parkinson’s disease

Length of the lipid chains predicts a person's risk for Parkinson’s disease

UVA researchers develop a noninvasive surgical approach to remove faulty brain circuits

UVA researchers develop a noninvasive surgical approach to remove faulty brain circuits

New combination of drugs could break down harmful protein aggregates in Parkinson's disease

New combination of drugs could break down harmful protein aggregates in Parkinson's disease

Study provides a new target for therapeutic intervention in Parkinson's disease

Study provides a new target for therapeutic intervention in Parkinson's disease

Researchers develop AI technology to generate CT images based on MRI

Researchers develop AI technology to generate CT images based on MRI

Research opens the door to new therapeutic options for Parkinson's disease

Research opens the door to new therapeutic options for Parkinson's disease

Northwestern scientists receive awards totaling nearly $18 million for Parkinson's disease research

Northwestern scientists receive awards totaling nearly $18 million for Parkinson's disease research

Researchers receive $8.9 million grant to study the gut-brain connection in Parkinson’s disease

Researchers receive $8.9 million grant to study the gut-brain connection in Parkinson’s disease

UVA researchers identify an unknown trigger for epilepsy seizures

UVA researchers identify an unknown trigger for epilepsy seizures

Use of wearable and wireless inertial sensor systems for treating movement disorders

Use of wearable and wireless inertial sensor systems for treating movement disorders

Children with cerebral palsy benefit most from higher doses of CIMT therapy

Children with cerebral palsy benefit most from higher doses of CIMT therapy

NYU Langone launches new center to advance scientific discovery and treatment of neurodegenerative diseases

NYU Langone launches new center to advance scientific discovery and treatment of neurodegenerative diseases

People with neurologic conditions more likely to have had adverse childhood experiences

People with neurologic conditions more likely to have had adverse childhood experiences

Cross-species locomotion features shared by dopamine-deficient worms, mice, and humans

Cross-species locomotion features shared by dopamine-deficient worms, mice, and humans

USC Stevens INI launches a $3 million study to solve some puzzles about Parkinson's disease

USC Stevens INI launches a $3 million study to solve some puzzles about Parkinson's disease

New type of algorithm simplifies comparisons between effects of electrical stimulation on the brain

New type of algorithm simplifies comparisons between effects of electrical stimulation on the brain

Researchers urge neurologists to actively encourage vaccinations for Parkinson's patients

Researchers urge neurologists to actively encourage vaccinations for Parkinson's patients

New compounds can provide a breakthrough in the treatment of neurodegenerative pathologies

New compounds can provide a breakthrough in the treatment of neurodegenerative pathologies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.